カテゴリ： Allied Market Research, 世界, 医療/バイオ

糖尿病性足病変（DFU）治療のグローバル市場（2023-2032）：創傷ケア包帯、創傷ケア用具、生物製剤、その他

■ 英語タイトル：Diabetic Foot Ulcer Treatment Market By Product (Wound care dressings, Wound care devices, Biologics, Others), By Type (Neuropathic ulcers, Ischemic ulcers, Neuroischemic ulcers), By End user (Hospitals, Homecare settings, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23SEP177）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23SEP177
■ 発行日：2023年6月
■ 調査対象地域：グローバル
■ 産業分野：生命科学
■ ページ数：296
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[糖尿病性足病変（DFU）治療のグローバル市場（2023-2032）：創傷ケア包帯、創傷ケア用具、生物製剤、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

糖尿病性足病変（DFU）は糖尿病の通常の深刻な合併症であり、世界中で何千万人もの人間に影響を及ぼしています。糖尿病性足病変（DFU）は、高血糖や糖尿病性神経障害（神経損傷）、末梢動脈疾患などを患う糖尿病患者の足にできる持続的な創傷です。さらに、糖尿病性足病変（DFU）の発症は、末梢神経障害、外傷、圧迫、創傷治癒能力の低下など、さまざまな要因が複合的に関係していることが多いのです。また、糖尿病では血糖値が高いため神経が損傷し、足の感覚が鈍くなり、怪我や傷の発見が困難になります。さらに、血行が悪いと足への酸素や栄養の供給が悪くなり、創傷治癒が損なわれます。さらに、糖尿病性足病変（DFU）を放置したり、管理が不十分であったりすると、感染症、組織壊死（死亡）、場合によっては切断などの重篤な合併症を引き起こす可能性があります。糖尿病性足病変（DFU）の管理には、創傷ケア用ドレッシング材や器具、オフローディングテクニック、感染管理、潰瘍発生の根本的要因への対処など、包括的なアプローチが必要です。
糖尿病性足病変（DFU）治療の発展を促進する主な要因は、糖尿病性足病変（DFU）に罹患する患者の増加、R&D運動の増加、適切な糖尿病性フットケアに関する意識の高まりです。糖尿病は、座りっぱなしの生活、不健康な食生活、肥満の増加などの要因によって、世界中で増加傾向にあります。さらに、血糖値が高い状態が長く続くと、足指の神経を傷つけ、感覚を鈍らせる末梢神経障害を引き起こす可能性があります。さらに、末梢動脈疾患として知られる血行不良は、足の創傷治癒を進めます。これらの要素は、糖尿病人口の増加と相まって、糖尿病性足病変（DFU）の頻度拡大の一因となっています。例えば、米国疾病管理予防センター（CDC）によると、2022年には糖尿病患者の約12％が糖尿病性足病変（DFU）を発症しています。このように、糖尿病性足病変（DFU）に罹患する患者の増加が、説得力のある治療オプションに対する要求を後押しし、それによって糖尿病性足病変（DFU）治療市場の発展を推進しています。

さらに、研究者や医療専門家は、糖尿病性足病変（DFU）の病態生理学の研究、新しい治療法の探求、既存の治癒手順の改善に積極的に取り組んでいます。先端技術の利用により、最新の創傷治療製品、生体工学に基づく毛穴や皮膚の代用品、オフローディング器具などが改良されています。これらの改良は、創傷治癒を促進し、感染症を予防し、糖尿病性足病変（DFU）のより良い管理方法を提供することを目的としています。さらに、再生医療の分野では、幹細胞、成長因子、組織工学による創傷治癒促進の可能性を探る研究が進行中です。製薬団体、教育機関、ヘルスケア企業による研究開発活動への資金提供の増加は、新規治療戦略の発明を拡大し、市場の成長を促進しています。

さらに、適切な糖尿病性フットケアに対する意識の高まりも、糖尿病性足病変（DFU）治療市場の成長に寄与しています。医療機関、糖尿病協会、医療専門家は、糖尿病患者のフットケアの重要性について積極的に関心を高めています。糖尿病性足病変（DFU）は、定期的な足の検査、適切な靴、足の衛生管理、足潰瘍の早期発見によって回避または最小限に抑えることができます。さらに、フットケアの実践を改善することを目的とした教育キャンペーンやイニシアチブは、患者の意識向上と参加率の向上につながりました。糖尿病性足病変（DFU）のリスクや結果に対する認識が高まるにつれて、適時に医師の診察を受け、予防策を遵守するようになります。このような意識の高まりは、患者の転帰を改善するだけでなく、糖尿病性足病変（DFU）の治療オプションに対する需要も促進しています。

世界の糖尿病性足病変（DFU）治療市場は、製品、タイプ、エンドユーザー、地域に区分されます。製品別では、創傷ケア用ドレッシング材、創傷ケア用デバイス、生物学的製剤、その他に分類されます。創傷ケア機器セグメントはさらに陰圧創傷治療とその他に分類されます。タイプ別では、神経障害性潰瘍、虚血性潰瘍、神経虚血性潰瘍に分類されます。エンドユーザー別では、病院、在宅介護環境、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域）、アジア太平洋地域（日本、中国、オーストラリア、インド、韓国、その他のアジア太平洋地域）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他のLAMEA地域）で分析されています。

世界の糖尿病性足病変（DFU）治療市場で事業を展開する主な主要企業は、ConvaTec Group plc、3M Company、Cardinal Health Inc.、Organogenesis Holdings Inc.、Smith and Nephew plc.、B. Braun SE、Coloplast、Integra LifeSciences Holdings Corporation、Molnlycke Health Care AB、Essity Aktiebolag ABです。主要プレーヤーは、製品ポートフォリオを拡大するために、買収、契約、製品発売、製品承認などの戦略を採用しています。

ステークホルダーにとっての主なメリット
本レポートは、2022年から2032年までの糖尿病性足病変（DFU）治療市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、糖尿病性足病変（DFU）治療市場の有力な市場機会を特定します。
糖尿病性足病変（DFU）治療の市場機会を特定するために、2022年から2032年までの糖尿病性足病変（DFU）治療市場の動向、予測、動態を分析します。
ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるようにします。
糖尿病性足病変（DFU）治療市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
糖尿病性足病変（DFU）治療薬市場の詳細なセグメンテーション分析により、市場機会を見極めることができます。
市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
地域別および世界の糖尿病性足病変（DFU）治療市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

主要市場セグメント
製品別
創傷被覆材
創傷治療用デバイス
タイプ
陰圧創傷治療
その他
生物製剤
その他

タイプ別
神経因性潰瘍
虚血性潰瘍
神経虚血性潰瘍

エンドユーザー別
病院
在宅ケア
その他

地域別
北米
米国
カナダ
メキシコ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
LAMEA
ブラジル
サウジアラビア
南アフリカ
その他の地域

主な市場プレイヤー
○ 3M Company
○ B. Braun SE
○ Cardinal Health Inc.
○ Coloplast
○ ConvaTec Group plc
○ Essity Aktiebolag AB
○ Integra LifeSciences Holdings Corporation
○ Molnlycke Health Care AB
○ ORGANOGENESIS HOLDINGS INC.
○ Smith and Nephew plc.

第1章：イントロダクション
第2章：エグゼクティブサマリー
第3章：市場概要
第4章：糖尿病性足病変（DFU）治療市場、製品別
第5章：糖尿病性足病変（DFU）治療市場、タイプ別
第6章：糖尿病性足病変（DFU）治療市場、エンドユーザー別
第7章：糖尿病性足病変（DFU）治療市場、地域別
第8章：競争状況
第9章：企業情報

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. High bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of diabetic foot ulcer
3.4.1.2. Technological advancements in wound care management
3.4.1.3. Rise in new product launches for diabetic foot ulcer treatment

3.4.2. Restraints
3.4.2.1. Stringent regulations for manufacturing of wound care products

3.4.3. Opportunities
3.4.3.1. Growing opportunity in emerging markets

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Wound care dressings
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Wound care devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Wound care devices Diabetic Foot Ulcer Treatment Market by Type
4.4. Biologics
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Others
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Neuropathic ulcers
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Ischemic ulcers
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Neuroischemic ulcers
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Homecare settings
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: DIABETIC FOOT ULCER TREATMENT MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Type
7.2.4. Market size and forecast, by End user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Type
7.2.5.1.4. Market size and forecast, by End user
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Type
7.2.5.2.4. Market size and forecast, by End user
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Type
7.2.5.3.4. Market size and forecast, by End user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Type
7.3.4. Market size and forecast, by End user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Type
7.3.5.1.4. Market size and forecast, by End user
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Type
7.3.5.2.4. Market size and forecast, by End user
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Type
7.3.5.3.4. Market size and forecast, by End user
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Type
7.3.5.4.4. Market size and forecast, by End user
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Type
7.3.5.5.4. Market size and forecast, by End user
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Type
7.3.5.6.4. Market size and forecast, by End user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Type
7.4.4. Market size and forecast, by End user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Type
7.4.5.1.4. Market size and forecast, by End user
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Type
7.4.5.2.4. Market size and forecast, by End user
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Type
7.4.5.3.4. Market size and forecast, by End user
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Type
7.4.5.4.4. Market size and forecast, by End user
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Type
7.4.5.5.4. Market size and forecast, by End user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Type
7.4.5.6.4. Market size and forecast, by End user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Type
7.5.4. Market size and forecast, by End user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Type
7.5.5.1.4. Market size and forecast, by End user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Type
7.5.5.2.4. Market size and forecast, by End user
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product
7.5.5.3.3. Market size and forecast, by Type
7.5.5.3.4. Market size and forecast, by End user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product
7.5.5.4.3. Market size and forecast, by Type
7.5.5.4.4. Market size and forecast, by End user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. ConvaTec Group plc
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. 3M Company
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Cardinal Health Inc.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. ORGANOGENESIS HOLDINGS INC.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Smith and Nephew plc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. B. Braun SE
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Coloplast
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Integra LifeSciences Holdings Corporation
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Molnlycke Health Care AB
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Essity Aktiebolag AB
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. DIABETIC FOOT ULCER TREATMENT MARKET FOR WOUND CARE DRESSINGS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. DIABETIC FOOT ULCER TREATMENT MARKET FOR WOUND CARE DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL WOUND CARE DEVICES DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 05. DIABETIC FOOT ULCER TREATMENT MARKET FOR BIOLOGICS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. DIABETIC FOOT ULCER TREATMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 08. DIABETIC FOOT ULCER TREATMENT MARKET FOR NEUROPATHIC ULCERS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. DIABETIC FOOT ULCER TREATMENT MARKET FOR ISCHEMIC ULCERS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. DIABETIC FOOT ULCER TREATMENT MARKET FOR NEUROISCHEMIC ULCERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 12. DIABETIC FOOT ULCER TREATMENT MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. DIABETIC FOOT ULCER TREATMENT MARKET FOR HOMECARE SETTINGS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. DIABETIC FOOT ULCER TREATMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. DIABETIC FOOT ULCER TREATMENT MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA DIABETIC FOOT ULCER TREATMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 21. U.S. DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 22. U.S. DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. CANADA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 24. CANADA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 25. CANADA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 28. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 30. EUROPE DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. EUROPE DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. EUROPE DIABETIC FOOT ULCER TREATMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 34. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 35. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 37. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 38. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. UK DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 40. UK DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 41. UK DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. ITALY DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 43. ITALY DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 44. ITALY DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 46. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 47. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 56. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 57. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. CHINA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 59. CHINA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 60. CHINA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. INDIA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 62. INDIA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 63. INDIA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 66. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 74. LAMEA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 75. LAMEA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA DIABETIC FOOT ULCER TREATMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 78. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 79. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA DIABETIC FOOT ULCER TREATMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA DIABETIC FOOT ULCER TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA DIABETIC FOOT ULCER TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. CONVATEC GROUP PLC: KEY EXECUTIVES
TABLE 90. CONVATEC GROUP PLC: COMPANY SNAPSHOT
TABLE 91. CONVATEC GROUP PLC: PRODUCT SEGMENTS
TABLE 92. CONVATEC GROUP PLC: PRODUCT PORTFOLIO
TABLE 93. CONVATEC GROUP PLC: KEY STRATERGIES
TABLE 94. 3M COMPANY: KEY EXECUTIVES
TABLE 95. 3M COMPANY: COMPANY SNAPSHOT
TABLE 96. 3M COMPANY: PRODUCT SEGMENTS
TABLE 97. 3M COMPANY: PRODUCT PORTFOLIO
TABLE 98. CARDINAL HEALTH INC.: KEY EXECUTIVES
TABLE 99. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
TABLE 100. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
TABLE 101. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
TABLE 102. CARDINAL HEALTH INC.: KEY STRATERGIES
TABLE 103. ORGANOGENESIS HOLDINGS INC.: KEY EXECUTIVES
TABLE 104. ORGANOGENESIS HOLDINGS INC.: COMPANY SNAPSHOT
TABLE 105. ORGANOGENESIS HOLDINGS INC.: PRODUCT SEGMENTS
TABLE 106. ORGANOGENESIS HOLDINGS INC.: PRODUCT PORTFOLIO
TABLE 107. ORGANOGENESIS HOLDINGS INC.: KEY STRATERGIES
TABLE 108. SMITH AND NEPHEW PLC.: KEY EXECUTIVES
TABLE 109. SMITH AND NEPHEW PLC.: COMPANY SNAPSHOT
TABLE 110. SMITH AND NEPHEW PLC.: PRODUCT SEGMENTS
TABLE 111. SMITH AND NEPHEW PLC.: PRODUCT PORTFOLIO
TABLE 112. SMITH AND NEPHEW PLC.: KEY STRATERGIES
TABLE 113. B. BRAUN SE: KEY EXECUTIVES
TABLE 114. B. BRAUN SE: COMPANY SNAPSHOT
TABLE 115. B. BRAUN SE: PRODUCT SEGMENTS
TABLE 116. B. BRAUN SE: PRODUCT PORTFOLIO
TABLE 117. COLOPLAST: KEY EXECUTIVES
TABLE 118. COLOPLAST: COMPANY SNAPSHOT
TABLE 119. COLOPLAST: PRODUCT SEGMENTS
TABLE 120. COLOPLAST: PRODUCT PORTFOLIO
TABLE 121. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 122. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 123. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT SEGMENTS
TABLE 124. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 125. MOLNLYCKE HEALTH CARE AB: KEY EXECUTIVES
TABLE 126. MOLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT
TABLE 127. MOLNLYCKE HEALTH CARE AB: PRODUCT SEGMENTS
TABLE 128. MOLNLYCKE HEALTH CARE AB: PRODUCT PORTFOLIO
TABLE 129. ESSITY AKTIEBOLAG AB: KEY EXECUTIVES
TABLE 130. ESSITY AKTIEBOLAG AB: COMPANY SNAPSHOT
TABLE 131. ESSITY AKTIEBOLAG AB: PRODUCT SEGMENTS
TABLE 132. ESSITY AKTIEBOLAG AB: PRODUCT PORTFOLIO
TABLE 133. ESSITY AKTIEBOLAG AB: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 慢性腎臓病（CKD）治療のグローバル市場（2023-2032）：薬剤、透析
  • 急性虚血性脳卒中診断＆治療のグローバル市場（2023-2032）：診断、治療
  • 脊髄性筋萎縮症（SMA）治療のグローバル市場（2023-2032）：タイプ1、タイプ2、その他
  • 鉄欠乏性貧血（IDA）治療のグローバル市場（2023～2030）：経口鉄剤治療、非経口鉄剤治療
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23SEP177 )"糖尿病性足病変（DFU）治療のグローバル市場（2023-2032）：創傷ケア包帯、創傷ケア用具、生物製剤、その他" (英文：Diabetic Foot Ulcer Treatment Market By Product (Wound care dressings, Wound care devices, Biologics, Others), By Type (Neuropathic ulcers, Ischemic ulcers, Neuroischemic ulcers), By End user (Hospitals, Homecare settings, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。